Nicholas Alvarez's most recent trade in LifeMD Inc was a trade of 100,000 Common Shares done . Disclosure was reported to the exchange on March 7, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 100,000 | 505,000 | - | 0 | Common Shares | |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 75,000 | 405,000 | - | 0 | Common Stock | |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Jul 2023 | 200,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 150,000 | 330,000 | - | - | Common Stock | |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 14 Jun 2023 | 10,712 | 180,000 | - | 2.9 | 31,279 | Common Stock |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2022 | 60,000 | 169,288 | - | 0 | Common Stock | |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 200,000 | 200,000 | - | - | Options to purchase Common Stock | |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.15 per share. | 27 Nov 2020 | 105,288 | 109,288 | - | 1.1 | 121,081 | Common Stock, par value $0.001 |
LifeMD Inc | Nicholas Alvarez | Chief Acquisition Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2020 | 105,288 | 0 | - | - | Options to purchase Common Stock |